论文部分内容阅读
目的探讨罗红霉素联合布地奈德气雾剂治疗支气管哮喘的临床疗效。方法将我院收治的121例支气管哮喘患者随机分为观察组和对照组,观察组61例,采用罗红霉素联合布地奈德气雾剂进行治疗,对照组60例,单纯采取吸入布地奈得气雾剂进行治疗,观察两组治疗后的临床疗效。结果两组患者肺功能治疗后较治疗前均明显改善,且观察组改善较对照组更为显著(P<0.05),观察组外周血EOS治疗前后比较差异显著(P<0.05),观察组临床疗效明显优于对照组(P<0.01)。结论罗红霉素联合布地奈德气雾剂治疗支气管哮喘疗效显著,值得临床推广应用。
Objective To investigate the clinical efficacy of roxithromycin combined with budesonide aerosol in the treatment of bronchial asthma. Methods 121 cases of bronchial asthma patients admitted to our hospital were randomly divided into observation group and control group, the observation group of 61 cases, the use of roxithromycin combined with budesonide aerosol treatment, the control group of 60 patients, simply taking inhaled clothinide Aerosol for treatment, observe the clinical efficacy of the two groups after treatment. Results Compared with the control group, the improvement of lung function in both groups was significantly improved after treatment (P <0.05), and the difference was significant (P <0.05) between the two groups before and after EOS treatment Efficacy was significantly better than the control group (P <0.01). Conclusion Roxithromycin combined with budesonide aerosol treatment of bronchial asthma significant effect, worthy of clinical application.